Archives

As a company who embraces the knowledge and diverse perspectives of all employees, Cardinal Health was again recognized among the nation's best workplaces for female advancement as a Top Company...

Cardinal Health (NYSE: CAH) today reported second-quarter fiscal year 2018 revenue of $35.2 billion, an increase of 6 percent. The company also reported a decline in GAAP operating earnings of 26...

Cardinal Health (NYSE: CAH) today announced that its board of directors has elected Akhil Johri, Executive Vice President and Chief Financial Officer of United Technologies, to the Cardinal Health...

Cardinal Health (NYSE:CAH) today announced that its board of directors approved a regular quarterly dividend of $0.4624 per share, payable April 15, 2018 to shareholders of record on April 2,...

Cardinal Health (NYSE: CAH) today announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma"). The sale...

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2018 on February 8 prior to the opening of trading on the New York Stock Exchange. The company...

DUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States...

Cardinal Health announced today that Mike Kaufmann, chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 8, 2018, at 11 a.m....

Cardinal Health Specialty Solutions today introduced the second edition of Oncology Insights, a research-based report outlining the views of more than 200 U.S. oncologists on the latest medical...

Cordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients...